Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programs -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and program funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Spain?
GlobalGov holds 2,728 pharmaceuticals records from 1,016 distinct buying organizations in Spain. The most frequent publishers are Osakidetza - Servicio Vasco De Salud - Organización Central (50 records); Consejería de Familia, Juventud y Asuntos Sociales (47 records); Consejería de Familia, Juventud y Política Social (37 records); OSAKIDETZA - Servicio Vasco de Salud - Organización Central (30 records); Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves (30 records); Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar (27 records). Between them the 6 largest account for 8.1% of everything published, so buying here is spread across many separate authorities.
| Buying organization | Records | Share |
|---|---|---|
| Osakidetza - Servicio Vasco De Salud - Organización Central | 50 | 1.8% |
| Consejería de Familia, Juventud y Asuntos Sociales | 47 | 1.7% |
| Consejería de Familia, Juventud y Política Social | 37 | 1.4% |
| OSAKIDETZA - Servicio Vasco de Salud - Organización Central | 30 | 1.1% |
| Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves | 30 | 1.1% |
| Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar | 27 | 1.0% |
What are pharmaceuticals contracts worth in Spain?
2,486 of the 2,728 records publish a contract value. The median is $2.1M and the largest single published value is $4.3B. By size, 27 under $100k, 674 between $100k and $1M, 1,390 between $1M and $10M, 395 above $10M. The remaining 242 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 27 | 1.1% |
| between $100k and $1M | 674 | 27% |
| between $1M and $10M | 1,390 | 56% |
| above $10M | 395 | 16% |
How long do bidders get to respond to pharmaceuticals tenders in Spain?
Across the 1,013 Spain pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 33 days. A quarter of them allowed 31 days or fewer and a quarter stayed open for more than 36. Short turnarounds are the exception rather than the rule here: only 9 (0.9%) closed within a fortnight of being published.
How often are pharmaceuticals tenders published in Spain?
Spain publishes about 42 notices a month in this category, 508 in the last twelve months. That is 18% more than the 429 published in the twelve months before that. Over the last three years there were 1,330, spread across 83 separate months of activity since 30 June 2016. July is historically the busiest month. The most recent was published 19 November 2026.
How does Spain compare with other pharmaceuticals markets?
Among the 45 countries where GlobalGov holds a comparable pharmaceuticals market, Spain ranks 6th by number of records. The largest is Poland (9,417 records against 2,728 here). Within Spain itself, pharmaceuticals is the 9th largest of the 74 procurement categories tracked here.
Where do the Spain pharmaceuticals records on this page come from?
These 2,728 records are collected from 2 official sources: TED (2,710), Plataforma de Contratación del Sector Público (18). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-11-22.
Open Pharmaceuticals tenders in Spain
Showing 4 of the 7 notices open in this category today. Openness uses the same definition as the Spain market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.
Provision of drug analyzer, indicia drug kits in saliva and the service of sample removal and confirmatory analysis for the Local Police Service of the City of Palma del Río (Córdoba)
Service for the prevention of occupational risks in the specialty of occupational medicine (health surveillance) and the three technical areas of specialization (work safety, industrial hygiene and ergonomics and applied psychosociology) at the City of Alcázar de San Juan and OOAA.
Spain – Pharmaceutical products – Dynamic system for acquiring the supply of authorised and marketed active substances: reference, generic, biosimilar and/or hybrid medicinal products
Other procurement categories in Spain
Pharmaceuticals procurement in other markets
Never Miss a Spain Government Contract
Finding Spain tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial